PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Living near major roads may increase risk of sudden cardiac death in women

American Heart Association Rapid Access Journal Report

2014-10-13
(Press-News.org) Living close to a major road may increase women's risk of dying from sudden cardiac death, according to new research in the American Heart Association journal Circulation. "It's important for healthcare providers to recognize that environmental exposures may be under-appreciated risk factors for diseases such as sudden cardiac death and fatal coronary heart disease," said Jaime E. Hart, Sc.D., study lead author and an instructor in medicine at Brigham and Women's Hospital and Harvard Medical School in Boston, Massachusetts. "On a population level, living near a major roadway was as important a risk factor as smoking, diet or obesity." While researchers previously found a modest increase in coronary heart disease risk among people who live near major roadways, the new study may be the first to examine the impact of roadway proximity to the risk of sudden cardiac death. Researchers note that roadway proximity could be a marker for exposure to air pollution. The researchers studied data from 107,130 women (predominately white, average age 60) who were part of the Nurses' Health Study from 1986-2012. Calculating residential distance to roadways and after adjusting for a large number of other factors including age, race, calendar time, cigarette smoking, physical activity, and diet, researchers found: In 523 cases of sudden cardiac death, living within 50 meters (164 feet) of a major road increased the risk of sudden cardiac death by 38 percent, compared to living at least 500 meters (.3 miles) away. Each 100 meters (328 feet) closer to roadways was associated with a 6 percent increased risk for sudden cardiac death. In the 1,159 cases of fatal coronary heart disease, risk increased 24 percent. The public's exposure to major roadways is comparable to major sudden cardiac death risk factors, researchers said. Researchers weren't able to measure all possible risk factors associated with living near a major road. They also said more research is needed among men and among women of different ages, races and income levels because nearly all participants were middle-age to elderly, white and of middle- to upper-socioeconomic class. The Environmental Protection Agency estimated that 35 million people in the United States lived within 300 meters (984 feet) of a major road in 2009, and a growing number lived in close proximity to major roads worldwide. "Regardless of where you live, adopting heart-healthy habits, such as maintaining a healthy weight, being physically active, eating nutritious foods, quitting smoking, and managing stress, can help decrease your risk of heart and blood vessel disease," said Hart, who is also an instructor at the Harvard School of Public Health. "Our next step is to try to determine what specific exposures, such as air pollution, are driving the association between heart disease and major roadway proximity."

INFORMATION:

Co-authors are Christine Albert, M.D.; Francine Laden, Sc.D.; and Stephanie E. Chiuve, Sc.D. Author disclosures are on the manuscript. The National Institutes of Health and American Heart Association funded the study.

Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association's policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at http://www.heart.org/corporatefunding.



ELSE PRESS RELEASES FROM THIS DATE:

Guideline offers direction in genetic testing for certain types of muscular dystrophy

2014-10-13
MINNEAPOLIS – A new guideline from the American Academy of Neurology (AAN) and the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) recommends guidance on how doctors should evaluate the full picture—from symptoms, family history and ethnicity to a physical exam and certain lab test results—in order to determine what genetic tests may best diagnose a person's subtype of limb-girdle or distal muscular dystrophy. The guideline is published in the October 14, 2014, print issue of Neurology®, the medical journal of the American ...

Study estimates 14 million smoking-attributable major medical conditions in US

2014-10-13
Bottom Line: Adults in the United States suffered from approximately 14 million major medical conditions attributable to smoking. Author: Brian L. Rostron, Ph.D., M.P.H., of the Center for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, Md., and colleagues. Background: Smoking is the leading cause of preventable disease in the United States. Cigarette smoking harms nearly every organ and organ system in the body. The authors estimated major medical conditions (morbidity) attributed to smoking in 2009. How the Study Was Conducted: The authors ...

No association seen between physical activity, depressive symptoms in adolescents

2014-10-13
Bottom Line: A study of teenagers suggests there is no association between physical activity (PA) and the development of depressive symptoms later in adolescence. Author: Umar Toseeb, Ph.D., of the University of Cambridge, United Kingdom, and colleagues. Background: Depression contributes to the global burden of disease. A reduction in the associated costs – both personal and financial – would benefit society. The onset of depression is thought to happen in adolescence or earlier so preventive measures during this period of life could be beneficial. PA ...

Dysregulation in orexinergic system associated with Alzheimer disease

2014-10-13
Bottom Line: In patients with Alzheimer disease (AD), increased cerebrospinal fluid levels of orexin, which helps regulate the sleep-wake cycle, may be associated with sleep deterioration, which appears to be associated with cognitive decline. Authors: Claudio Liguori, M.D., of the University of Rome Tor Vergata, Italy, and colleagues. Background: AD is a neurodegenerative disease marked by progressive memory loss and cognitive decline and often complicated by sleep disturbance. Orexin A is part of the orexinergic system and it helps regulate the sleep-wake cycle ...

Chemical derived from broccoli sprouts shows promise in treating autism

Chemical derived from broccoli sprouts shows promise in treating autism
2014-10-13
Results of a small clinical trial suggest that a chemical derived from broccoli sprouts — and best known for claims that it can help prevent certain cancers — may ease classic behavioral symptoms in those with autism spectrum disorders (ASDs). The study, a joint effort by scientists at MassGeneral Hospital for Children and the Johns Hopkins University School of Medicine, involved 40 teenage boys and young men, ages 13 to 27, with moderate to severe autism. In a report published online in the journal Proceedings of the National Academy of Sciences during ...

Chemical present in broccoli, other vegetables may improve autism symptoms

2014-10-13
A small study led by investigators at MassGeneral Hospital for Children (MGHfC) and Johns Hopkins University School of Medicine has found evidence that daily treatment with sulforaphane – a molecule found in foods such as broccoli, cauliflower and cabbage – may improve some symptoms of autism spectrum disorders. In their report being published online in PNAS Early Edition, the investigators describe how participants receiving a daily dose of sulforaphane showed improvement in both behavioral and communication assessments in as little as four weeks. The authors ...

Greater rates of mitochondrial mutations discovered in children born to older mothers

Greater rates of mitochondrial mutations discovered in children born to older mothers
2014-10-13
The discovery of a "maternal age effect" by a team of Penn State scientists that could be used to predict the accumulation of mitochondrial DNA mutations in maternal egg cells -- and the transmission of these mutations to children -- could provide valuable insights for genetic counseling. These mutations cause more than 200 diseases and contribute to others such as diabetes, cancer, Parkinson's disease, and Alzheimer's disease. The study found greater rates of the mitochondrial DNA variants in children born to older mothers, as well as in the mothers themselves. The research ...

Paving the way for a fructose tolerance test

2014-10-13
BOSTON – Increased consumption of table sugar and high-fructose corn syrup has been linked to rising rates of obesity and type 2 diabetes in the United States and throughout the world. Both sweeteners are commonly found in processed foods and sugar-sweetened beverages, and both are made up of nearly equal amounts of two basic sugars, glucose and fructose. The effects of glucose ingestion in humans are well understood, in part, because they are easily assessed by performing a Glucose Tolerance Test, which measures serum glucose levels after glucose ingestion and ...

Moderate levels of 'free radicals' found beneficial to healing wounds

2014-10-13
Long assumed to be destructive to tissues and cells, "free radicals" generated by the cell's mitochondria—the energy producing structures in the cell—are actually beneficial to healing wounds. That's the conclusion of biologists at UC San Diego who discovered that "reactive oxygen species"—chemically reactive molecules containing oxygen, such as peroxides, commonly referred to as free radicals—are necessary for the proper healing of skin wounds in the laboratory roundworm C. elegans. In a paper published in the October 13 issue of the journal ...

New cancer drug to begin trials in multiple myeloma patients

2014-10-13
Scientists at Imperial College London have developed a new cancer drug which they plan to trial in multiple myeloma patients by the end of next year. In a paper published today in the journal Cancer Cell, the researchers report how the drug, known as DTP3, kills myeloma cells in laboratory tests in human cells and mice, without causing any toxic side effects, which is the main problem with most other cancer drugs. The new drug works by stopping a key process that allows cancer cells to multiply. The team have been awarded Biomedical Catalyst funding from the Medical ...

LAST 30 PRESS RELEASES:

Study links wind-blown dust from receding Salton Sea to reduced lung function in area children

Multidisciplinary study finds estrogen could aid in therapies for progressive multiple sclerosis

Final day of scientific sessions reveals critical insights for clinical practice at AAO-HNSF Annual Meeting and OTO EXPO

Social adversity and triple-negative breast cancer incidence among black women

Rapid vs standard induction to injectable extended-release buprenorphine

Galvanizing blood vessel cells to expand for organ transplantation

Common hospice medications linked to higher risk of death in people with dementia

SNU researchers develop innovative heating and cooling technology using ‘a single material’ to stay cool in summer and warm in winter without electricity

SNU researchers outline a roadmap for next-generation 2D semiconductor 'gate stack' technology

The fundamental traditional Chinese medicine constitution theory serves as a crucial basis for the development and application of food and medicine homology products

Outfoxed: New research reveals Australia’s rapid red fox invasion

SwRI’s Dr. Chris Thomas named AIAA Associate Fellow

National Collegiate Athletic Association (NCAA) funding for research on academic advising experiences of Division I Black/African American student-athletes at minority serving institutions

Johri developing artificial intelligence literacy among undergraduate engineering and technology students

Boston Children’s receives a $35 million donation to accelerate development of therapeutic options for children with brain disorders through the Rosamund Stone Zander and Hansjoerg Wyss Translational

Quantum crystals offer a blueprint for the future of computing and chemistry

Looking beyond speech recognition to evaluate cochlear implants

Tracking infectious disease spread via commuting pattern data

Underweight children cost the NHS as much per child as children with obesity, Oxford study finds.

Wetland plant-fungus combo cleans up ‘forever chemicals’ in a pilot study

Traditional Chinese medicine combined with peginterferon α-2b in chronic hepatitis B

APS and SPR honor Dr. Wendy K. Chung with the 2026 Mary Ellen Avery Neonatal Research Award

The Gabriella Miller Kids First Data Resource Center (Kids First DRC) has launched the Variant Workbench

Yeast survives Martian conditions

Calcium could be key to solving stability issues in sodium-ion batteries

Can smoother surfaces prevent hydrogen embrittlement?

Heart rate changes predict depression treatment success with magnetic brain stimulation

Genetics pioneer transforms global depression research through multi-omics discoveries

MDMA psychiatric applications synthesized: Comprehensive review examines PTSD treatment and emerging therapeutic indications

Psychedelics offer new therapeutic framework for stress-related psychiatric disorders

[Press-News.org] Living near major roads may increase risk of sudden cardiac death in women
American Heart Association Rapid Access Journal Report